We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
TScan Therapeutics Inc | NASDAQ:TCRX | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
7.30 | 7.40 | 7.40 | 7.116 | 7.34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 21.05M | -89.22M | -1.8633 | -3.97 | 354.33M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
18:29:53 | 1 | 7.3096 | USD |
Date | Time | Source | Headline |
---|---|---|---|
29/8/2023 | 13:02 | DJN | TScan Gets FDA Clearance of Investigational New Drug Application for Cancer.. |
06/6/2023 | 15:25 | DJN | TScan Therapeutics Shares Rise 17% After FDA Clears IND for Cancer.. |
26/5/2023 | 00:50 | DJN | Stocks to Watch: Marvell Technology, Workday, Gap, TScan Therapeutics |
09/5/2023 | 15:08 | DJN | TScan Therapeutics Shares Take Flight on Amgen Pact |
09/5/2023 | 14:48 | DJN | Amgen, TScan Therapeutics Set Crohn's Disease Collaboration |
TScan Therapeutics (TCRX) Share Charts1 Year TScan Therapeutics Chart |
|
1 Month TScan Therapeutics Chart |
Intraday TScan Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions